{
    "clinical_study": {
        "@rank": "93923", 
        "arm_group": {
            "arm_group_label": "UltheraTM", 
            "arm_group_type": "Experimental", 
            "description": "UltheraTM 100 shots (infraorbital region 30shots, lateral orbital region 40shots, upper eyelid 30 shots) on the Rt, and Lt periorbital area, respectively using 1.5mm and 3.0mm probe"
        }, 
        "brief_summary": {
            "textblock": "Study title\n\n        -  Safety and Efficacy Evaluation of UltheraTM in Treatment of Baggy Eyelid Study design\n\n        -  single arm and Investigator Initiative pilot study"
        }, 
        "brief_title": "Safety and Efficacy Evaluation of UltheraTM in Treatment of Baggy Eyelid", 
        "completion_date": {
            "#text": "February 2013", 
            "@type": "Actual"
        }, 
        "condition": "Orbital Fat Prolapse", 
        "condition_browse": {
            "mesh_term": "Prolapse"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age \uff1e20 years, Age \uff1c 50 years\n\n          -  people who want to improve baggy eyelid\n\n          -  Information consent obtained\n\n        Exclusion Criteria:\n\n          -  previous lower eyelid surgical history\n\n          -  scar on  lower eyelid after trauma\n\n          -  bleeding tendency\n\n          -  aesthetic addiction, drug abuse, alcohol abuse"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "7", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 18, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01693055", 
            "org_study_id": "E-1207/162-004", 
            "secondary_id": "L-2012-408-3"
        }, 
        "intervention": {
            "arm_group_label": "UltheraTM", 
            "description": "UltheraTM 100 shots (infraorbital region 30shots, lateral orbital region 40shots, upper eyelid 30 shots) on the Rt, and Lt periorbital area, respectively using 1.5mm and 3.0mm probe", 
            "intervention_name": "UltheraTM 100 shots", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "orbital Computed Tomography", 
            "baggy eyelids", 
            "orbital fat prolapse", 
            "UltheraTM", 
            "high intensity focused ultrasound"
        ], 
        "lastchanged_date": "April 4, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seongnam-si,", 
                    "country": "Korea, Republic of", 
                    "state": "Gyeonggi-do", 
                    "zip": "463-707"
                }, 
                "name": "Seoul National Univ. Bundang Hospital, Gumi-dong, Bundang-gu"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "1", 
        "official_title": "Safety and Efficacy Evaluation of UltheraTM in Treatment of Baggy Eyelid,Phase 4.", 
        "overall_official": {
            "affiliation": "Seoul National University Bundang Hospital", 
            "last_name": "Chanyeong Heo, Ph.D", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Difference  between the distance ( from the inferior orbital   rim to the skin) measured by orbital CT at Screening and 12weeks after UltheraTM treatment", 
            "measure": "The distance from the inferior orbital rim to the skin", 
            "safety_issue": "Yes", 
            "time_frame": "Change from Screening in distance at 12weeks after Ulthera treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01693055"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Seoul National University Hospital", 
            "investigator_full_name": "Chan-Yeong Heo", 
            "investigator_title": "Assistant professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "The distance(mm),from the most protrusive baggy eyelid to the orbital septum will be measured by a plastic surgeon with orbital CT films. Each participant will do Orbital CT scan 2 times, at screening and 12weeks after treatment", 
                "measure": "The distance from the most protrusive baggy eyelid to the orbital septum", 
                "safety_issue": "No", 
                "time_frame": "Change from Screening in distance at 12weeks after UltheraTM treatment"
            }, 
            {
                "description": "5-point scale for Subject Satisfaction in baggy lower eyelid. The subject satisfaction is calculated as a score between 0 and 4( 0= very poor, 4= very good).", 
                "measure": "Subject Satisfaction for baggy lower eyelid", 
                "safety_issue": "No", 
                "time_frame": "Change from Screening in satisfaction at 4 weeks and 12weeks"
            }, 
            {
                "description": "Improvement of baggy lower eyelid will be assessed by Two plastic surgeons. Both assessors will evaluate Improvement of baggy lower eyelid including skin laxity and orbital fat prolapse using 5-point scale.\n0= no involvement\nmild\nmoderate\nmarked\nsevere", 
                "measure": "Improvement of baggy lower eyelid", 
                "safety_issue": "No", 
                "time_frame": "Change from Screening in  baggy lower eyelid at 12weeks after UltheraTM treatment"
            }
        ], 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "Ulthera, Inc", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}